Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RPIDthis companyRapid Micro Biosystems, Inc.	$0.62	-2.76×	3.9×	3.86×	-3.12×	-2924.7%	22.7%	-141.1%	-140.3%	-141.9%	-82.2%	-24.6%	0.72×	-0.09×	-43.48×	3.31×	0.0%	2	-14.26	1	D+
APYXApyx Medical Corporation	$2.95	-12.96×	10.15×	2.79×	-33.8×	-284.7%	36.0%	-12.2%	-21.2%	-77.1%	-11.6%	-6.2%	2.71×	-1.66×	-1.15×	5×	0.0%	3	0.84	1	D+
CGTXCognition Therapeutics, Inc.	$0.69	-4.22×	2.87×	0×	-2.67×	-14.9%	0.0%	0.0%	0.0%	-68.5%	-136.9%	-25.0%	0.02×	1.56×	-3,676.85×	3.45×	0.0%	1	-0.97	2	C+
LNSRLENSAR Inc	$5.62	-4.05×	-5.34×	2.38×	-4.33×	-927.5%	46.4%	-42.1%	-58.7%	131.7%	-77.8%	-10.7%	-0.11×	0.34×	0×	1.15×	0.0%	5	0.85	4	A-
LUCDLucid Diagnostics Inc.	$0.42	-1.58×	10.16×	23.61×	-1.79×	-873.4%	-60.3%	-1054.8%	-1232.7%	-530.4%	-135.1%	-41.8%	2.36×	0.16×	-2,256.36×	1.31×	0.0%	3	-13.58	2	C
NSPRInspireMD, Inc.	$0.68	-2.34×	2.37×	14.56×	-2.59×	-939.0%	29.5%	-547.0%	-543.3%	-88.4%	-82.2%	-28.1%	0.06×	0.12×	0×	5.74×	0.0%	2	-11.16	2	C+
Peer median	—	-4.05×	2.87×	2.79×	-2.67×	-873.4%	29.5%	-42.1%	-58.7%	-77.1%	-82.2%	-25.0%	0.06×	0.16×	-1.15×	3.45×	0.0%	3	-0.97	2	—